litlas
Log inCreate account

Derek T. O’Hagan

Active 1989–2024

Also published as
Derek T. O'Hagan
120
Papers
20,498
Citations
87
h-index
120
i10-index

Citations

Citations per year for Derek T. O’Hagan1974: 1 citations1990: 3 citations1991: 5 citations1992: 6 citations1993: 30 citations1994: 31 citations1995: 35 citations1996: 61 citations1997: 62 citations1998: 123 citations1999: 63 citations2000: 60 citations2001: 110 citations2002: 85 citations2003: 155 citations2004: 183 citations2005: 126 citations2006: 153 citations2007: 137 citations2008: 152 citations2009: 191 citations2010: 170 citations2011: 210 citations2012: 192 citations2013: 172 citations2014: 184 citations2015: 191 citations2016: 152 citations2017: 151 citations2018: 172 citations2019: 430 citations2020: 530 citations2021: 782 citations2022: 684 citations2023: 587 citations2024: 844 citations2025: 374 citations2026: 5 citations1975–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,827 citing papers, 27.7% of this breakdownChina: 801 citing papers, 12.2% of this breakdownUnited Kingdom: 415 citing papers, 6.3% of this breakdownIndia: 249 citing papers, 3.8% of this breakdownGermany: 244 citing papers, 3.7% of this breakdownItaly: 233 citing papers, 3.5% of this breakdownCanada: 205 citing papers, 3.1% of this breakdownSwitzerland: 200 citing papers, 3% of this breakdownAustralia: 188 citing papers, 2.9% of this breakdownFrance: 188 citing papers, 2.9% of this breakdownSouth Korea: 169 citing papers, 2.6% of this breakdownNetherlands: 161 citing papers, 2.4% of this breakdown
0%27.7%Other 25.9%

Institutions

Fields

  • Immunology and Microbiology31.9%
  • Medicine26%
  • Biochemistry, Genetics and Molecular Biology24.1%
  • Pharmacology, Toxicology and Pharmaceutics9.1%
  • Agricultural and Biological Sciences2.6%
  • Materials Science2.3%
  • Other4%

Topics

  • Immunotherapy and Immune Responses12.5%
  • RNA Interference and Gene Delivery9.4%
  • SARS-CoV-2 and COVID-19 Research4.9%
  • Advanced Drug Delivery Systems4.2%
  • Immune Response and Inflammation4%
  • Immune Cell Function and Interaction2.9%
  • Other62.1%

Coauthors

All papers

Open in search
  1. Emerging concepts in the science of vaccine adjuvants

    Authors: Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan - Nature Reviews Drug Discovery 2021 cited by 1,356

  2. Nonviral delivery of self-amplifying RNA vaccines

    Authors: Andrew J. Geall, Ayush Verma, Gillis R. Otten, Christine A. Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W. Beard, Luis A. Brito, Thomas Krucker, Derek T. O’Hagan, Manmohan Singh, Peter W. Mason, Nicholas M. Valiante, Philip R. Dormitzer, Susan W. Barnett, Rino Rappuoli, Jeffrey B. Ulmer, Christian W. Mandl - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 667

  3. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

    Authors: Prabhu S. Arunachalam, Alexandra C. Walls, Nadia Golden, Caroline Atyeo, Stephanie Fischinger, Chunfeng Li, Pyone P. Aye, Mary Jane Navarro, Lilin Lai, Venkata Viswanadh Edara, Katharina Röltgen, Kenneth A. Rogers, Lisa Shirreff, Douglas E. Ferrell, Samuel Wrenn, Deleah Pettie, John C. Kraft, Marcos C. Miranda, Elizabeth Kepl, Claire Sydeman, Natalie Brunette, Michael Murphy, Brooke Fiala, Lauren Carter, Alexander G. White, Meera Trisal, Ching‐Lin Hsieh, Kasi Russell‐Lodrigue, Christopher Monjure, Jason Dufour, Skye Spencer, Lara Doyle‐Meyers, Rudolph P. Bohm, Nicholas J. Maness, Chad J. Roy, Jessica A. Plante, Kenneth S. Plante, Alex Zhu, Matthew J. Gorman, Sally Shin, Xiaoying Shen, Jane Fontenot, Shakti Gupta, Derek T. O’Hagan, Robbert van der Most, Rino Rappuoli, Robert L. Coffman, David Novack, Jason S. McLellan, Shankar Subramaniam, David C. Montefiori, Scott D. Boyd, JoAnne L. Flynn, Galit Alter, François Villinger, Harry Kleanthous, Jay Rappaport, Mehul S. Suthar, Neil P. King, David Veesler, Bali Pulendran - Nature 2021 cited by 353

  4. A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

    Authors: Luis A. Brito, Michelle Y. Chan, Christine A. Shaw, Armin Hekele, Thomas Carsillo, Mary Schaefer, Jacob Archer, Anja Seubert, Gillis R. Otten, Clayton W. Beard, Antu Dey, Anders Lilja, Nicholas M. Valiante, Peter W. Mason, Christian W. Mandl, Susan W. Barnett, Philip R. Dormitzer, Jeffrey B. Ulmer, Manmohan Singh, Derek T. O’Hagan, Andrew J. Geall - Molecular Therapy 2014 cited by 333

  5. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines

    Authors: Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo - Molecular Pharmaceutics 2021 cited by 145

  6. Mechanism of action of mRNA-based vaccines

    Authors: Carlo Iavarone, Derek T. O’Hagan, Dong Yü, Nicolas F. Delahaye, Jeffrey B. Ulmer - Expert Review of Vaccines 2017 cited by 247

  7. Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

    Authors: Harm HogenEsch, Derek T. O’Hagan, Christopher B. Fox - npj Vaccines 2018 cited by 392

  8. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

    Authors: Alexandra C. Walls, Marcos C. Miranda, Alexandra Schäfer, Minh N. Pham, Allison J. Greaney, Prabhu S. Arunachalam, Mary-Jane Navarro, M. Alejandra Tortorici, Kenneth A. Rogers, Megan A. O’Connor, Lisa Shirreff, Douglas E. Ferrell, John E. Bowen, Natalie Brunette, Elizabeth Kepl, Samantha K. Zepeda, Tyler N. Starr, Ching‐Lin Hsieh, Brooke Fiala, Samuel Wrenn, Deleah Pettie, Claire Sydeman, Kaitlin R. Sprouse, Max Johnson, Alyssa Blackstone, Rashmi Ravichandran, Cassandra Ogohara, Lauren Carter, Sasha W. Tilles, Rino Rappuoli, Sarah R. Leist, David R. Martinez, Matthew Clark, Roland Tisch, Derek T. O’Hagan, Robbert van der Most, Wesley C. Van Voorhis, Davide Corti, Jason S. McLellan, Harry Kleanthous, Timothy P. Sheahan, Kelly D. Smith, Deborah H. Fuller, François Villinger, Jesse D. Bloom, Bali Pulendran, Ralph S. Baric, Neil P. King, David Veesler - Cell 2021 cited by 192

  9. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency

    Authors: Giulia Anderluzzi, Gustavo Lou, Stuart Woods, S. Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie - Journal of Controlled Release 2021 cited by 96

  10. The mechanism of action of MF59 – An innately attractive adjuvant formulation

    Authors: Derek T. O’Hagan, Gary Ott, Ennio De Gregorio, Anja Seubert - Vaccine 2012 cited by 475

  11. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection

    Authors: Gustavo Lou, Giulia Anderluzzi, S. Schmidt, Stuart Woods, Simona Gallorini, Michela Brazzoli, Fabiola Giusti, Ilaria Ferlenghi, Russell N. Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner, Yvonne Perrie - Journal of Controlled Release 2020 cited by 164

  12. Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines

    Authors: Roshan Goswami, Despo Chatzikleanthous, Gustavo Lou, Fabiola Giusti, Alessandra Bonci, Marianna Taccone, Michela Brazzoli, Simona Gallorini, Ilaria Ferlenghi, Francesco Berti, Derek T. O’Hagan, Carlo Pergola, Barbara C. Baudner, Roberto Adamo - ACS Infectious Diseases 2019 cited by 112

  13. “World in motion” – emulsion adjuvants rising to meet the pandemic challenges

    Authors: Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, Margherita Coccia, Giuseppe Lofano - npj Vaccines 2021 cited by 111

  14. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake

    Authors: Frank Liang, Gustaf Lindgren, Kerrie J. Sandgren, Elizabeth A. Thompson, Joseph R. Francica, Anja Seubert, Ennio De Gregorio, Susan W. Barnett, Derek T. O’Hagan, Nancy J. Sullivan, Richard A. Koup, Robert A. Seder, Karin Loré - Science Translational Medicine 2017 cited by 209

  15. The history of MF59 ® adjuvant: a phoenix that arose from the ashes

    Authors: Derek T. O’Hagan, Gary Ott, Gary Van Nest, Rino Rappuoli, Giuseppe Del Giudice - Expert Review of Vaccines 2012 cited by 311

  16. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine

    Authors: Yupeng Feng, Meng Yuan, John M. Powers, Mengyun Hu, Jennifer E. Munt, Prabhu S. Arunachalam, Sarah R. Leist, Lorenza Bellusci, JungHyun Kim, Kaitlin R. Sprouse, Lily E. Adams, Sumana Sundaramurthy, Xueyong Zhu, Lisa Shirreff, Michael L. Mallory, Trevor Scobey, Alberto Moreno, Derek T. O’Hagan, Harry Kleanthous, François Villinger, David Veesler, Neil P. King, Mehul S. Suthar, Surender Khurana, Ralph S. Baric, Ian A. Wilson, Bali Pulendran - Science Translational Medicine 2023 cited by 62

  17. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

    Authors: Fiona A. Sharp, Darren Ruane, Benjamin Claass, Emma M. Creagh, James Harris, Padma Malyala, Manomohan Singh, Derek T. O’Hagan, Virginie Pétrilli, Jürg Tschopp, Luke O'neill, Ed C. Lavelle - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 536

  18. The continued advance of vaccine adjuvants – ‘we can work it out’

    Authors: Derek T. O’Hagan, Rushit N. Lodaya, Giuseppe Lofano - Seminars in Immunology 2020 cited by 107

  19. Rational design of small molecules as vaccine adjuvants

    Authors: Tom Wu, Manmohan Singh, Andrew T. Miller, Ennio De Gregorio, Francesco Doro, Ugo D’Oro, David Skibinski, M. Lamine Mbow, Simone Bufali, Ann Herman, Alex Cortez, Yongkai Li, Bishnu P. Nayak, Elaine Tritto, Christophe Filippi, Gillis R. Otten, Luis A. Brito, Elisabetta Monaci, Chun Li, Susanna Aprea, Sara Valentini, Samuele Calabrό, Donatello Laera, Brunella Brunelli, Elena Caproni, Padma Malyala, Rekha G. Panchal, Travis K. Warren, Sina Bavari, Derek T. O’Hagan, M. Cooke, Nicholas M. Valiante - Science Translational Medicine 2014 cited by 176

  20. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect

    Authors: Samuele Calabrό, Elaine Tritto, Annamaria Pezzotti, Marianna Taccone, Alessandro Muzzi, Sylvie Bertholet, Ennio De Gregorio, Derek T. O’Hagan, Barbara C. Baudner, Anja Seubert - Vaccine 2013 cited by 215

  21. Molecular and cellular signatures of human vaccine adjuvants

    Authors: Flaviana Mosca, Elaine Tritto, Alessandro Muzzi, Elisabetta Monaci, Fábio Bagnoli, Carlo Iavarone, Derek T. O’Hagan, Rino Rappuoli, Ennio De Gregorio - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 493

  22. Recent advances in the discovery and delivery of vaccine adjuvants

    Authors: Derek T. O’Hagan, Nicholas M. Valiante - Nature Reviews Drug Discovery 2003 cited by 432

  23. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

    Authors: Samuele Calabrό, Marco Tortoli, Barbara C. Baudner, Alessandra Pacitto, Mario Cortese, Derek T. O’Hagan, Ennio De Gregorio, Anja Seubert, Andreas Wack - Vaccine 2011 cited by 427

  24. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus

    Authors: Fábio Bagnoli, Maria Rita Fontana, Elisabetta Soldaini, Ravi P.N. Mishra, Luigi Fiaschi, Elena Cartocci, Vincenzo Nardi‐Dei, Paolo Ruggiero, Sarah Nosari, Maria Grazia De Falco, Giuseppe Lofano, Sara Marchi, Bruno Galletti, Paolo Mariotti, Marta Bacconi, Antonina Torre, Silvia Maccari, Maria Scarselli, C. Daniela Rinaudo, Naoko Inoshima, Silvana Savino, Elena Mori, Silvia Rossi-Paccani, Barbara C. Baudner, Michele Pallaoro, Erwin Swennen, Roberto Petracca, Cecilia Brettoni, Sabrina Liberatori, Nathalie Norais, Elisabetta Monaci, Juliane Bubeck Wardenburg, Olaf Schneewind, Derek T. O’Hagan, Nicholas M. Valiante, Giuliano Bensi, Sylvie Bertholet, Ennio De Gregorio, Rino Rappuoli, Guido Grandi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 174